TP53 and breast cancer: To this end, we examined the associations of Yes1 mRNA expression with prognosis of breast cancer patients using two independent datasets, such as 236 breast cancer patients with/without TP53 mutation (TP53 cohort, GSE3494) and 204 breast cancer patients with distant metastasis (metastasis cohort, GSE12276).